Can fish help you focus? Yes, if you eat it and it’s chock full of those PUFAs we call “omega-3”: EPA and DHA. Check out this for more background. I think of EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) as “brain building blocks” though this is more true for DHA than EPA. These molecules slot into membranes, improve neuronal signaling, tilt inflammation toward resolution (EPA), and alter dopaminergic circuitry that can shift the balance of power between focus and fragmentation. Consuming omega-3s is playing the long-game for cognition – they are an investment in optimal brain health over the course of months-to-years rather than minutes.¹ ² ³

---

The Multimodal Mechanisms:

Membranes are where the magic happens. Synapses (where two neurons communicate) are gaps between membranes with neurotransmitters being released on one end and receptors receiving those signals on the other. When the membrane is rigid, signaling is not optimal. Picture this like a person trying to dance with their hands in their pockets. Sure, they can vibe a little, but it’s awkward. DHA is long and kinked, it gets integrated into the membrane and suddenly there is much more fluidity in the movement within the membrane itself (where receptors are lodged). Receptors can function better, move in and out as needed, and neuronal signaling, the very basis of thought, improves.¹

Inflammation needs a resolution. EPA/DHA compete with arachidonic acid (AA) for the same enzymes. As we tilt the balance toward omega-3s and away from omega-6s (i.e. AA) we make fewer pro-inflammatory eicosanoids and more pro-resolving mediators (resolvins, protectins, maresins). Don’t worry about memorizing the names, just remember that omega-3s don’t stop inflammation from starting (we need inflammation to respond to problems), it helps stop inflammation after it has served its purpose. In brains running “flaming hot” (metabolic dysfunction, aging, chronic stress), dialing down cytokine storms triggered by inflammation improves vigilance and reduces errors.² This immune mediation also manifests in neutrophils migrating less aggressively. Less chemotaxis (neutrophil surges) → less spillover "cytokine noise" that otherwise hurts cognition during stress or illness.⁴

Dopaminergic tone, tweaked. Prefrontal attention and response inhibition rely on dopamine. Omega-3 deficiency worsens dopaminergic function in the brain; repletion normalizes synthesis/release/receptor signaling in animal and cellular work - it’s no surprise then, that sustained attention and impulse control improve in response to omega-3 levels rising.³

Form and meal matter. Ethyl-ester (EE) fish oil with a low-fat snack is a poor plan; absorption is limited and you aren’t getting the benefits you think you are. Triglyceride/free-fatty-acid forms absorb more reliably. If you do use EE (the form in Goldmind:Focus, FYI), take them with a real meal containing fat (classic PK work shows ≈ 3× better uptake) and this makes absorption roughly equivalent to TG/FFA forms.⁵ ⁶

---

The Various Fish Effect Sizes

Current status in the U.S.: not great, Bob. NHANES 2011–2012 puts adult serum EPA around ~0.6% and DHA ~1.4% of total fatty acids; the majority of Americans sit in a low Omega-3 status band that correlates with poorer cardiometabolic and brain markers.⁷

Healthy young adults. In randomized trials, EPA-rich oil improved composite attention/executive performance; DHA-rich oil raised DHA status but didn’t show much on cognition tests. The estimated cognitive effect: SMD ≈ 0.20–0.30 over weeks. I’ll discuss EPA and DHA amounts below needed to yield these results. This isn’t an effect size that changes your life overnight, but IS larger than the effect size for D-amphetamine (primary component of Adderall) in healthy adults (read this).⁸

Youth with attentional symptoms. Meta-analysis across clinical trials shows ADHD symptom improvement ≈0.38 SD, and in trials that measured cognition directly, attention-task gains ≈1.09 SD (smaller evidence base; heterogeneous). The EPA dose matters (again, see below).⁹ An effect size that reaches 1 SD is nothing to scoff at and about 3x larger than the effect size of SSRIs in treating adults with depression, for reference.

Middle-aged/older adults without dementia. A 2024 systematic review with dose–response modeling found global cognition unchanged (SMD ≈ 0.04), but executive function improved with adequate dosing and time. Something consistent through almost all of these studies is that signal strengthens when total omega-3s, but especially EPA is ≥ 500 mg/day for 6–12 months.¹⁰

Long-horizon brain aging (observational). Higher long-chain omega-3 status (RBC DHA or EPA+DHA) associates with larger total/hippocampal volumes years later and lower incident dementia; one Framingham analysis reported ≈ 47% lower all-cause dementia in the top DHA quartile vs bottom. Here the important caveat that observational ≠ causal, but this is not trivial and if the intervention has essentially negligible side effects, a study like this lends credence to the “investment’ frame for omega-3s and brain health.¹¹ ¹² ¹³ ¹⁴ I absolutely take an omega-3 supplement daily based on data like this. 

---

For the fish traditionalists:

To level-set, if you want to go the whole-food route instead of (or alongside) supplemental soft gels:

• Salmon (Atlantic, farmed), 3–4 oz cooked: ~1.2–1.8 g EPA+DHA per serving.
  

• Salmon (wild), 3–4 oz cooked: ~1.0–1.4 g EPA+DHA.
  

• Anchovies (canned, in oil), 2–3 oz drained: ~1.0–1.5 g EPA+DHA.

Two “real” servings per week (e.g., 2x 4-oz salmon) delivers ~2–3.5 g EPA+DHA/week (~300–500 mg/day average). Add a small, daily anchovy habit and you’re effectively at 1 gram/day without trying very hard. You can also do this with supplementation, which is the path I personally go down for my omega-3 intake.

---

What to take, how to take, and how long it takes

If you’re going to supplement for general cognitive benefits, the goal is a high-quality, EPA-dominant supplement with DHA present. For most healthy adults optimizing attention, ~1 g/day EPA+DHA with a real, fat-containing meal is a practical default. Expect SMD ≈ 0.2–0.3 improvements in executive-control composites over 12–16 weeks. These are neuronal building blocks and inflammatory soothers - they do not light up your nucleus accumbens like a psychostimulant; you will not feel euphoric or racy. They are a slow, subtle improvement to your mental milieu over months.⁵ ⁶ ⁸ ¹⁰ 

Measuring progress is actually possible. The Omega-3 Index (RBC EPA+DHA %) exists and is a practical scoreboard available at Amazon for $55. You take a drop of blood and mail it to the lab with results in a couple of weeks. Typical U.S. adults are around ~4–5% (low) while the target is ~8–12% for “ideal.” With ~1 g/day EPA+DHA (and good absorption), most people rise ~2% in ~3–4 months (remember that RBC turnover ~120 days, so don’t re-measure after a week). Doubling the intake of your omega-3 supplement, consuming more salmon or improving form/meal pairing (remember to take that EE with food!) can move faster (~3–4% in the same horizon). Plan on 8–16 weeks to reach your number; re-check.¹¹ ¹² ¹⁴ This test isn’t measuring what is going on with omega-3s in the brain exactly, but it’s the best we’ve got short of a brain biopsy, which I, for one, am not volunteering for.

---

References

1. Shahidi F, Ambigaipalan P. Omega-3 Polyunsaturated Fatty Acids and Their Health Benefits. Annu Rev Food Sci Technol. 2018;9:345–381.
   

2. Calder PC. Omega-3 fatty acids and inflammatory processes. Nutrients. 2010;2(3):355–374.
   

3. Healy-Stoffel M, Levant B. n-3 (Omega-3) Fatty Acids: Effects on Brain Dopamine Systems. CNS Neurol Disord Drug Targets. 2018;17(3):216–232.
   

4. Schmidt EB, Pedersen JO, Varming K, Ernst E, Jersild C, Grunnet N, Dyerberg J. n-3 fatty acids and leukocyte chemotaxis: dose-response in healthy males. Arterioscler Thromb. 1991;11:429–435.
   

5. Nordøy A, Barstad L, Connor WE, Hatcher L. Absorption of EPA and DHA as ethyl esters and triglycerides by humans. Am J Clin Nutr. 1991;53:1185–1190.
   

6. Lawson LD, Hughes BG. Absorption of EPA and DHA from fish-oil triacylglycerols or ethyl esters co-ingested with a high-fat meal. Biochem Biophys Res Commun. 1988;156(2):960–963.
   

7. Murphy RA, Devarshi PP, Ekimura S, Marshall K, Mitmesser SH. Long-chain omega-3 fatty acid serum concentrations across life stages in the USA: NHANES 2011–2012. BMJ Open. 2021;11:e043301.
   

8. Patan MJ, Kennedy DO, Husberg C, Hustvedt S-O, Calder PC, et al. EPA-rich, but not DHA-rich, oil improves global cognitive function in healthy young adults: randomized controlled trials. Am J Clin Nutr. 2021;114(3):914–924.
   

9. Chang J-P-C, Su K-P, Mondelli V, Pariante CM. Omega-3 polyunsaturated fatty acids in youths with ADHD: systematic review and meta-analysis. Neuropsychopharmacology. 2018;43:534–545.
   

10. Suh SW, Lim E, Burm S-Y, et al. n-3 PUFAs and cognitive function in individuals without dementia: systematic review and dose–response meta-analysis. BMC Med. 2024;22:109.
    

11. Tan ZS, Harris WS, Beiser AS, et al. Red blood cell omega-3 fatty acid levels and markers of accelerated brain aging. Neurology. 2012;78:658–664.
    

12. Pottala JV, Yaffe K, Robinson JG, et al. Higher RBC EPA+DHA corresponds with larger total brain and hippocampal volumes years later. Neurology. 2014;82:435–442.
    

13. Schaefer EJ, Bongard V, Beiser AS, et al. Plasma phosphatidylcholine DHA and risk of dementia and Alzheimer disease: Framingham Heart Study. Arch Neurol. 2006;63:1545–1550.
    

14. Sala-Vila A, Satizabal CL, Harris WS, et al. Red blood cell DHA is inversely associated with incident Alzheimer’s disease and all-cause dementia: Framingham Offspring. Nutrients. 2022;14(12):2408.